Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.

Journal of clinical pathology - 1 Mar 2015

Manson-Bahr David, Ball Richard, Gundem Gunes, Sethia Krishna, Mills Robert, Rochester Mark, Goody Victoria, Anderson Elizabeth, O'Meara Sarah, Flather Marcus, Keeling Matthew, Yazbek-Hanna Marcelino, Hurst Rachel, Curley Helen, Clark Jeremy, Brewer Daniel S, McDermott Ultan, Cooper Colin

Abstract excerpt

AIMS: Assessing whether next-generation DNA sequencing (NGS) can be used to screen prostate cancer for multiple gene alterations in men routinely diagnosed with this disease and/or who are entered into clinical trials. Previous studies are limited and have reported only low success rates. METHODS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Fixatives

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Formaldehyde

Share to Kallikreins

Share to Neoplasm Grading

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Tissue Fixation

Source

Identifiers

PMID: 25586381
DOI: 10.1136/jclinpath-2014-202754

Genes

ATM
ERG
MEN1
NBPF10
NCOR2
SPOP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25586381-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.PMID 25586381Read ↗

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.Semantic proximity Read ↗

A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.Semantic proximity Read ↗

Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.Semantic proximity Read ↗

The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies.Semantic proximity Read ↗

Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testingSemantic proximity Read ↗

Detection of disease-causing mutations in prostate cancer by NGS sequencing.Semantic proximity Read ↗

The role of genetic testing in prostate cancer screening, diagnosis, and treatment.Semantic proximity Read ↗

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingSemantic proximity Read ↗

Identification of somatic mutations in human prostate cancer by RNA-SeqSemantic proximity Read ↗

Integrative molecular profiling of routine clinical prostate cancer specimens.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samplesSemantic proximity Read ↗

Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.